Skip to main content

LCD L39913: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)

LCD L39913, Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA), is the Local Coverage Determination that Wisconsin Physicians Service Insurance Corporation applies to claims from 48 states (AK, AL, AR, AZ, CA, CO, CT, DE and others), effective 2025-02-28 and first in force 2024-11-24. The policy text runs 1,098 words, and its billing and coding article A57552 lists 223 ICD-10-CM codes that support medical necessity for 4 procedure codes. 4 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 224 covered ICD-10-CM codes: 223 more codes than L39840 (CGS Administrators, LLC, 1 code, revised 2025-02-14) and 223 more codes than L39851 (Palmetto GBA, 1 code, revised 2026-10-15).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Wisconsin Physicians Service Insurance Corporation
States and territories
48
AK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS MT NC ND NE NH NJ NM NV OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY
Revision effective
2025-02-28
Original effective
2024-11-24
Policy text
1,098 words
Covered ICD-10 codes (articles)
224

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L39913
ContractContractorTypeStates
05101Wisconsin Physicians Service Insurance CorporationMAC - Part AIA
05201Wisconsin Physicians Service Insurance CorporationMAC - Part AKS
05301Wisconsin Physicians Service Insurance CorporationMAC - Part AMO
05401Wisconsin Physicians Service Insurance CorporationMAC - Part ANE
05102Wisconsin Physicians Service Insurance CorporationMAC - Part BIA
05202Wisconsin Physicians Service Insurance CorporationMAC - Part BKS
05302Wisconsin Physicians Service Insurance CorporationMAC - Part BMO
05402Wisconsin Physicians Service Insurance CorporationMAC - Part BNE
08101Wisconsin Physicians Service Insurance CorporationMAC - Part AIN
08102Wisconsin Physicians Service Insurance CorporationMAC - Part BIN
08201Wisconsin Physicians Service Insurance CorporationMAC - Part AMI
08202Wisconsin Physicians Service Insurance CorporationMAC - Part BMI
05901Wisconsin Physicians Service Insurance CorporationMAC - Part AAK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS MT NC ND NE NH NJ NM NV OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY

Billing and coding articles A57552 and A59813: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57552 (Billing and Coding: Coronary Computed Tomography Angiography (CCTA)), Billing and Coding A59813 (Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)) carry the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57552: Billing and Coding: Coronary Computed Tomography Angiography (CCTA) (Billing and Coding, effective 2026-10-29)

Covered ICD-10-CM codes
223
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
4
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57552
ICD-10-CMDescription (FY2027)
C38.0Malignant neoplasm of heart
C45.2Mesothelioma of pericardium
C79.89Secondary malignant neoplasm of other specified sites
C79.9Secondary malignant neoplasm of unspecified site
D15.1Benign neoplasm of heart
I20.0Unstable angina
I20.1Angina pectoris with documented spasm
I20.81Angina pectoris with coronary microvascular dysfunction
I20.89Other forms of angina pectoris
I24.0Acute coronary thrombosis not resulting in myocardial infarction
I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
I25.112Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
I25.119Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
I25.2Old myocardial infarction
I25.3Aneurysm of heart
I25.41Coronary artery aneurysm
I25.42Coronary artery dissection
I25.5Ischemic cardiomyopathy
I25.6Silent myocardial ischemia
I25.700Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
I25.701Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm

Procedure codes: 75571, 75572, 75573, 75574.

A59813: Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) (Billing and Coding, effective 2026-01-01)

Covered ICD-10-CM codes
1
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
1
Full article
cms.gov record
First 1 covered ICD-10-CM codes in A59813
ICD-10-CMDescription (FY2027)
R93.1Abnormal findings on diagnostic imaging of heart and coronary circulation

Procedure codes: 75577.

Coverage indications, limitations and medical necessity

AI-QCT/AI-CPA using CCTA* is considered reasonable and medically necessary as a diagnostic study when:

• The patient has acute or stable chest pain with no known coronary artery disease (CAD) 1 and is eligible for CCTA*, AND

• CCTA classifies patient as:

• Intermediate risk ** OR

• CAD-RADS 1, CAD-RADS 2, or CAD-RADS 3*** category on CCTA 1,2 , AND

• Cardiac evaluation is negative or inconclusive for acute coronary syndrome (ACS) 1

*See L35121 for criteria for CCTA. AI-QCT/AI-CPA should not be performed until after the base study (CCTA) has been completed and interpreted. Software to perform AI-QCT/AI-CPA must be FDA cleared or approved.

**Intermediate and high-risk as defined in the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain 1

*** CAD-RADS 1- CAD-RADS 3 category as defined by CAD-RADS™ 2.0–2022 Coronary Artery Disease Reporting and Data System (CAD-RADS): an Expert Consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). 2,3

Limitations

Software to perform AI-CPA must be FDA cleared or approved.

AI-QCT/AI-CPA is NOT considered reasonable or necessary in the following clinical circumstance (non-covered):

• Screening, i.e., in the absence of signs, symptoms, or disease.

• When there is a contraindication to CCTA*

• In conjunction with invasive coronary catheterization

• In the presence of normal CCTA results (CAD RADS=0 or no plaque disease)

• In the presence of high grade stenosis (>70%) or CAD RADS-4 and RADS-5

• Within 30 days of a myocardial infarction (MI).

• In the presence of unstable coronary symptoms

• For disease surveillance

*See CCTA policy (L35121) for full listing of contraindications.

Definitions

Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) - Artificial intelligence application to imaging obtained through coronary CT scans to calculate coronary artery dimensions and degree of stenosis per vessel and coronary plaque composition and burden. 4

Calcified Plaque - Higher density plaque, mostly composed of calcium, thought to be associated with lower clinical risk than non-calcified plaque. Traditionally, the overall burden of calcified plaque has been assessed indirectly through a coronary artery calcium score (CACS) or using cut off >350 HU. 5 There is both calcified and non-calcified tissue present 6 .

Coronary Artery Disease (CAD) - Narrowing of the coronary arteries usually caused by plaque and atherosclerosis that can lead to ischemia of the heart. 1

• Known CAD includes patient with prior anatomic testing with identified nonobstructive atherosclerotic plaque and obstructive CAD. 1

Coronary Artery Disease Reporting and Data System (CAD-RADS) - A standardized method to communicate findings of CCTA. 2

Category

Degree of maximal coronary stenosis

Interpretation

CAD-RADS 0

0%

Absence of CAD

CAD-RADS 1

1-24%

Minimal non-obstructive CAD

CAD-RADS 2

25-49%

Mild non-obstructive CAD

CAD-RADS 3

50-69%

Moderate stenosis

CAD-RADS 4

70-99% or left main ≥50% or 3-vessel obstructive (≥70%) disease

Severe stenosis

CAD-RADS 5

100%

Total coronary artery occlusion or sub-total occlusion

CAD-RADS N

Non-diagnostic study

Obstructive CAD cannot be excluded

Coronary Computed Tomography Angiography (CCTA) - a non-invasive test using advanced computed tomography angiography imaging to view the tissues and blood vessels of the heart. This can be used to determine the presence and extent of CAD.

Coronary Plaque Analysis (CPA) - Analysis of coronary plaque composition and burden.

Fibrotic Plaque - A plaque with density of 131-350 HU.

High Risk Plaque (HRP) - High risk plaque findings include napkin-ring sign, low-attenuation plaque, positive vessel remodeling, low CT attenuation and spotty calcification. 5,7

Invasive Coronary Angiography (ICA) - Invasive procedure done at the time of cardiac catheterization to look at the arteries of the heart and can determine the presence and extent of CAD.

Low Attenuation Plaque (LAP) -Low density plaque with dark appearance on CCTA and higher lipid content usually defined as attenuation of 5,8

Major Adverse Cardiac Events (MACE) - Fatal and non-fatal myocardial infarction. Some studies also include unstable angina requiring hospitalization or revascularization. 7

Non-Calcified Plaque (NCP) – A lower density plaque, often earlier in development and associated with higher clinical risk with density of 50-130 HU. 5,8 There is no discernible calcification present. 6

Nonobstructive CAD - CAD with 1

Obstructive CAD - CAD with >50% stenosis 1

Plaque -The presence of tissue structures ≥ 1mm 2 within or adjacent to the coronary artery lumen, identified and at least 2 independent planes, that can be distinguished from the surrounding tissues (epicardial fat) and the lumen. 6

Quantitative Coronary Plaque Analysis (QCPA) - Imaging technique that provides objective and reproducible measurements of coronary artery dimensions and composition of the atherosclerotic plaques.

Quantitative Coronary Topography (QCT) - CT scan imaging that provides objective and reproducible measurements of the coronary artery dimensions and degree of stenosis per vessel.

Provider Qualifications

The Medicare Program Integrity Manual states services will be considered medically reasonable and necessary only if performed by appropriately trained providers.

Patient safety and quality of care mandate that healthcare professionals who interpret CCTA and QCPA and AI-QCT/AI-CPA are appropriately trained and/or credentialed by a formal residency/fellowship program. Credentialing or privileges are required for procedures performed in inpatient and outpatient settings. 4

All aspects of care must be within the provider’s medical licensure and scope of practice. Reimbursement for procedures utilizing imaging techniques may be made to providers who meet training requirements for the procedures in this policy only if their respective state allows such in their practice act and formally licenses or certifies the practitioner to use and interpret these imaging modalities. At a minimum, training must cover and develop an understanding of anatomy and drug pharmacodynamics and kinetics as well as proficiency in diagnosis and management of disease, the technical performance of the procedure, and utilization of the required associated imaging modalities. Supervision, interpretation, and reports shall/must be performed by a physician with the advanced training requirements and/or credentialing for CCTA and AI-QCT/AI-CPA. The technical and professional portions must meet the criteria for performance for CCTA (L35121).

Providers must also meet the FDA requirements which includes “The software is not intended to replace the skill and judgment of a qualified medical practitioner and should only be used by people who have been appropriately trained in the software’s functions, capabilities and limitations.” 9 Radiology technicians must also meet all training requirements for performance of AI-QCT/AI-CPA.

Notice: Services performed for any given diagnosis must meet all the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, all existing CMS national coverage determinations, and all Medicare payment rules.

Summary of evidence (opening)

A Contractor Advisory Meeting “Non-Invasive Technology for Coronary Artery Plaque Analysis” was hosted 5/25/23 by CGS Administrators, Noridian Healthcare Solutions, National Government Services, Palmetto GBA, and WPS Government Health Administrators. The transcript and audio are available on each MAC's website.

Background

CCTA has become an effective gate keeper for invasive angiography, helping guide referral for obstructive CAD. It has been demonstrated to be superior to exercise electrocardiography and single-photon emission computed tomography (SPECT) for detection of obstructive CAD (>50% stenosis). 10,11 Studies have demonstrated excellent prognostic value of a normal CCTA for both short and long term mortality rates. 12 The updated 2021 American College of Cardiology and American Heart Association Chest Pain Guideline 1 states CCTA has become a first line tool in evaluation of acute and chronic coronary artery disease, particularly in symptomatic patients with stable symptoms and intermediate or high pre-test probability of obstructive coronary artery disease, or among intermediate-risk acute chest pain patients.

CCTA can also provide information on plaque burden and adverse coronary artery plaque characteristics which has been demonstrated to be an independent predictor of disease and prognosis. 12 The characterization of coronary atherosclerotic plaques can be calculated from CCTA, but the process is time consuming and often with variable results. 4,13 At least 5 different software have been developed as an adjunct to CCTA to aid in the visualization, reduce evaluation time, and improve accuracy of this assessment. The gold standard is considered intravascular ultrasound (IVUS) and optical coherence tomography (OCT) which are the tools that are often used to validate the software. 5 This is intended to improve clinical diagnosis and management of CAD. 14

The contractor cites 80 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2024-11-24
Current revision effective
2025-02-28
MCD version
7

Other related documents: A59937 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Wisconsin Physicians Service Insurance Corporation hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L39913 cover?

• The patient has acute or stable chest pain with no known coronary artery disease (CAD) 1 and is eligible for CCTA*, AND The full 1,098-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L39913 apply to?

Wisconsin Physicians Service Insurance Corporation applies it to Medicare claims in 48 states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. It binds only that contractor; 4 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L39913?

The companion billing and coding article A57552 lists 223 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L39913?

A denial under LCD L39913 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57552's 223 covered diagnosis codes, then file a redetermination with Wisconsin Physicians Service Insurance Corporation within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.